Skip to main content
Erschienen in: Lung 4/2016

20.06.2016

Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans

verfasst von: Jonas Eckrich, Eva Herrmann, Sandra Voss, Ralf Schubert, Stefan Zielen, Martin Rosewich

Erschienen in: Lung | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bronchiolitis obliterans (BO) is an inadequately researched disease in terms of lung function as well as inflammatory profile. The short-term variation of these parameters has not been investigated. Therefore, the objective of this study was the investigation of lung function, sputum cells and cytokine profiles in BO at two visits within of four to six weeks.

Methods

Twenty patients with BO (median age = 14.6, range 8.3–24.3) performed lung function tests, airway reversibility testing and induction of sputum within four to six weeks. The cell composition in the sputum was analysed and cytokine levels of IL-1ß, IL-6 and IL-8 were determined by cytometric bead array analysis. The short-term variation was then statistically quantified and compared to that of twenty-two healthy controls. Furthermore, we compared data on short-term variation of lung function and airway inflammation with a previous investigation in these patients 10–15 months earlier.

Results

Patients with BO showed minimal variation of lung function (VCmax, FVC, FEV1, FEV1/VC, MEF25 and RV/TLC) and the inflammatory cell profile. The lung function data were significantly lower for FVC, FEV1, the Tiffeneau index and MEF25 compared to the control group, whereas RV/TLC was significantly increased. Analysis of the BO sputum cells showed a consistent neutrophil inflammation. The levels of inflammatory cytokines IL-1ß, IL-6 and IL-8 had a great variability.

Conclusions

The short-term variability of sputum neutrophilia and lung function is low in BO patients. This finding should be considered to identify successful treatment in the individual patient and could be used as endpoints for future BO-related studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Verleden SE, Vasilescu DM, Willems S, Ruttens D, Vos R, Vandermeulen E, Hostens J, McDonough JE, Verbeken EK, Verschakelen J, Van Raemdonck DE, Rondelet B, Knoop C, Decramer M, Cooper J, Hogg JC, Verleden GM, Vanaudenaerde BM (2014) The site and nature of airway obstruction after lung transplantation. Am J Respir Crit care Med 189(3):292–300. doi:10.1164/rccm.201310-1894OC CrossRefPubMed Verleden SE, Vasilescu DM, Willems S, Ruttens D, Vos R, Vandermeulen E, Hostens J, McDonough JE, Verbeken EK, Verschakelen J, Van Raemdonck DE, Rondelet B, Knoop C, Decramer M, Cooper J, Hogg JC, Verleden GM, Vanaudenaerde BM (2014) The site and nature of airway obstruction after lung transplantation. Am J Respir Crit care Med 189(3):292–300. doi:10.​1164/​rccm.​201310-1894OC CrossRefPubMed
2.
Zurück zum Zitat Hardy KA, Schidlow DV, Zaeri N (1988) Obliterative bronchiolitis in children. Chest 93(3):460–466CrossRefPubMed Hardy KA, Schidlow DV, Zaeri N (1988) Obliterative bronchiolitis in children. Chest 93(3):460–466CrossRefPubMed
3.
Zurück zum Zitat Aguerre V, Castanos C, Pena HG, Grenoville M, Murtagh P (2010) Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatric Pulm 45(12):1180–1185. doi:10.1002/ppul.21304 CrossRef Aguerre V, Castanos C, Pena HG, Grenoville M, Murtagh P (2010) Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatric Pulm 45(12):1180–1185. doi:10.​1002/​ppul.​21304 CrossRef
4.
Zurück zum Zitat Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T, Robin M, Ribaud P, Socie G, Tazi A (2013) Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplant 48(6):819–824. doi:10.1038/bmt.2012.241 CrossRefPubMed Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T, Robin M, Ribaud P, Socie G, Tazi A (2013) Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplant 48(6):819–824. doi:10.​1038/​bmt.​2012.​241 CrossRefPubMed
6.
Zurück zum Zitat Castro-Rodriguez JA, Daszenies C, Garcia M, Meyer R, Gonzales R (2006) Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatric Pulmonol 41(10):947–953. doi:10.1002/ppul.20472 CrossRef Castro-Rodriguez JA, Daszenies C, Garcia M, Meyer R, Gonzales R (2006) Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatric Pulmonol 41(10):947–953. doi:10.​1002/​ppul.​20472 CrossRef
8.
Zurück zum Zitat Kim CK, Kim SW, Kim JS, Koh YY, Cohen AH, Deterding RR, White CW (2001) Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest 120(4):1101–1106CrossRefPubMed Kim CK, Kim SW, Kim JS, Koh YY, Cohen AH, Deterding RR, White CW (2001) Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest 120(4):1101–1106CrossRefPubMed
9.
Zurück zum Zitat Alvarez AE, Marson FA, Bertuzzo CS, Arns CW, Ribeiro JD (2013) Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. J Pediatr 89(6):531–543. doi:10.1016/j.jped.2013.02.022 CrossRef Alvarez AE, Marson FA, Bertuzzo CS, Arns CW, Ribeiro JD (2013) Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. J Pediatr 89(6):531–543. doi:10.​1016/​j.​jped.​2013.​02.​022 CrossRef
10.
Zurück zum Zitat Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR, Committee IAEBTF, Committee IAEBTF (2014) An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur respir J 44(6):1479–1503. doi:10.1183/09031936.00107514 CrossRefPubMed Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR, Committee IAEBTF, Committee IAEBTF (2014) An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur respir J 44(6):1479–1503. doi:10.​1183/​09031936.​00107514 CrossRefPubMed
11.
14.
18.
Zurück zum Zitat Eickmeier O, Huebner M, Herrmann E, Zissler U, Rosewich M, Baer PC, Buhl R, Schmitt-Grohe S, Zielen S, Schubert R (2010) Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine 50(2):152–157. doi:10.1016/j.cyto.2010.02.004 CrossRefPubMed Eickmeier O, Huebner M, Herrmann E, Zissler U, Rosewich M, Baer PC, Buhl R, Schmitt-Grohe S, Zielen S, Schubert R (2010) Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine 50(2):152–157. doi:10.​1016/​j.​cyto.​2010.​02.​004 CrossRefPubMed
22.
Zurück zum Zitat Barisione G, Bacigalupo A, Crimi E, Brusasco V (2011) Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation. Chest 139(3):633–639. doi:10.1378/chest.10-1442 CrossRefPubMed Barisione G, Bacigalupo A, Crimi E, Brusasco V (2011) Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation. Chest 139(3):633–639. doi:10.​1378/​chest.​10-1442 CrossRefPubMed
26.
Zurück zum Zitat Cazzato S, Poletti V, Bernardi F, Loroni L, Bertelli L, Colonna S, Zappulla F, Timoncini G, Cicognani A (2008) Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatric Pulm 43(4):381–390. doi:10.1002/ppul.20784 CrossRef Cazzato S, Poletti V, Bernardi F, Loroni L, Bertelli L, Colonna S, Zappulla F, Timoncini G, Cicognani A (2008) Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatric Pulm 43(4):381–390. doi:10.​1002/​ppul.​20784 CrossRef
29.
Zurück zum Zitat Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C (2015) A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax. doi:10.1136/thoraxjnl-2014-205998 Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C (2015) A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax. doi:10.​1136/​thoraxjnl-2014-205998
30.
Zurück zum Zitat Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM (2008) A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 32(4):832–843. doi:10.1183/09031936.00134307 CrossRefPubMed Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM (2008) A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 32(4):832–843. doi:10.​1183/​09031936.​00134307 CrossRefPubMed
31.
Zurück zum Zitat Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE (2006) Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 174(5):566–570. doi:10.1164/rccm.200601-071OC CrossRefPubMed Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE (2006) Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 174(5):566–570. doi:10.​1164/​rccm.​200601-071OC CrossRefPubMed
32.
Zurück zum Zitat Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, Schoonis A, Nawrot TS, Dupont LJ, Verleden GM (2011) A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 37(1):164–172. doi:10.1183/09031936.00068310 CrossRefPubMed Vos R, Vanaudenaerde BM, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Van Raemdonck DE, Schoonis A, Nawrot TS, Dupont LJ, Verleden GM (2011) A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 37(1):164–172. doi:10.​1183/​09031936.​00068310 CrossRefPubMed
34.
Zurück zum Zitat Hechinger AK, Smith BA, Flynn R, Hanke K, McDonald-Hyman C, Taylor PA, Pfeifer D, Hackanson B, Leonhardt F, Prinz G, Dierbach H, Schmitt-Graeff A, Kovarik J, Blazar BR, Zeiser R (2015) Therapeutic activity of multiple common gamma-chain cytokine inhibition in acute and chronic GVHD. Blood 125(3):570–580. doi:10.1182/blood-2014-06-581793 CrossRefPubMedPubMedCentral Hechinger AK, Smith BA, Flynn R, Hanke K, McDonald-Hyman C, Taylor PA, Pfeifer D, Hackanson B, Leonhardt F, Prinz G, Dierbach H, Schmitt-Graeff A, Kovarik J, Blazar BR, Zeiser R (2015) Therapeutic activity of multiple common gamma-chain cytokine inhibition in acute and chronic GVHD. Blood 125(3):570–580. doi:10.​1182/​blood-2014-06-581793 CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, Croze RH, Carlo T, Pfeffer MA, Levy BD (2013) Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol 6(2):256–266. doi:10.1038/mi.2012.66 CrossRefPubMed Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, Croze RH, Carlo T, Pfeffer MA, Levy BD (2013) Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol 6(2):256–266. doi:10.​1038/​mi.​2012.​66 CrossRefPubMed
36.
Zurück zum Zitat Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schone H, Kirsten AM, Magnussen H, Rabe KF, Goldmann T, Watz H (2015) Multi-analyte profiling of inflammatory mediators in COPD sputum–the effects of processing. Cytokine 71(2):401–404. doi:10.1016/j.cyto.2014.10.008 CrossRefPubMed Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schone H, Kirsten AM, Magnussen H, Rabe KF, Goldmann T, Watz H (2015) Multi-analyte profiling of inflammatory mediators in COPD sputum–the effects of processing. Cytokine 71(2):401–404. doi:10.​1016/​j.​cyto.​2014.​10.​008 CrossRefPubMed
Metadaten
Titel
Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans
verfasst von
Jonas Eckrich
Eva Herrmann
Sandra Voss
Ralf Schubert
Stefan Zielen
Martin Rosewich
Publikationsdatum
20.06.2016
Verlag
Springer US
Erschienen in
Lung / Ausgabe 4/2016
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9907-y

Weitere Artikel der Ausgabe 4/2016

Lung 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.